News & Events

Stay update
MolMed attending the 2nd European CAR T Cell Meeting di Sitges, Barcellona, with an update on the CAR T CD44v6 clinical trial

MolMed attending the 2nd European CAR T Cell Meeting di Sitges, Barcellona, with an update on the CAR T CD44v6 clinical trial